Skip to menu Skip to content Skip to footer
Dr Minyon Avent
Dr

Minyon Avent

Email: 

Overview

Background

Dr Avent obtained her Doctor of Pharmacy at the University of North Carolina Chapel Hill, United States of America. She has also obtained her certification as a board certified Pharmacotherapy Specialist and recently being credentialed as an Advanced Practice Pharmacist.

Availability

Dr Minyon Avent is:
Available for supervision

Qualifications

  • Doctor of Philosophy, unknown

Research interests

  • Antimicrobial Stewardship

    Dr Minyon Avent is an Antimicrobial Stewardship pharmacist at the School of Public Health, The University of Queensland. She has many years of experience in developing and implementing programmes for the appropriate use of antibiotics in tertiary health care institutions, rural and regional areas as well as the general practice setting.

  • Optimization of Antibiotic Dosing

    Dr Minyon Avent is a Consultant Clinical Research Pharmacist at The University of Queensland Centre for Clinical Research (UQCCR) where her research interests are the pharmacokinetic and pharmacodynamic optimisation of antibiotics

  • Appropriate use of Antibiotics

Research impacts

Dr Avent's area of expertise is Infectious Diseases which includes the development and implementation of Antimicrobial Stewardship programmes. She is the author of a number of peer-reviewed publications and has been invited to present her results at national and international conferences.

Works

Search Professor Minyon Avent’s works on UQ eSpace

50 works between 1992 and 2024

1 - 20 of 50 works

2024

Journal Article

Implementation of a quality improvement strategy to optimise the management of community acquired pneumonia in a rural health setting

Sally, Carrington, Gabrielle, Chau, Sidony, Miller Waugh, Christopher, Symmons, Justin, Titmarsh and Avent, Minyon L. (2024). Implementation of a quality improvement strategy to optimise the management of community acquired pneumonia in a rural health setting. Australian Journal of Rural Health, 32 (3), 560-568. doi: 10.1111/ajr.13116

Implementation of a quality improvement strategy to optimise the management of community acquired pneumonia in a rural health setting

2024

Journal Article

Developing an intervention package to optimise the management of vancomycin therapy using theory informed co-design

Avent, M.L., Franks, W., Redmond, A., Allen, M.J. and Naicker, S. (2024). Developing an intervention package to optimise the management of vancomycin therapy using theory informed co-design. Research in Social and Administrative Pharmacy, 20 (5), 498-505. doi: 10.1016/j.sapharm.2024.01.012

Developing an intervention package to optimise the management of vancomycin therapy using theory informed co-design

2023

Journal Article

Reducing antibiotic prescribing in general practice in Australia: a cluster randomised controlled trial of a multimodal intervention

Avent, Minyon L., Hall, Lisa, van Driel, Mieke, Dobson, Annette, Deckx, Laura, Galal, Mahmoud, Plejdrup Hansen, Malene and Gilks, Charles (2023). Reducing antibiotic prescribing in general practice in Australia: a cluster randomised controlled trial of a multimodal intervention. Australian Journal of Primary Health, 30 (1) ARTN PY23024, 1-10. doi: 10.1071/py23024

Reducing antibiotic prescribing in general practice in Australia: a cluster randomised controlled trial of a multimodal intervention

2023

Journal Article

Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study

Nolan, J., McCarthy, K., Farkas, A. and Avent, M. L. (2023). Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study. International Journal of Clinical Pharmacy, 45 (6), 1444-1451. doi: 10.1007/s11096-023-01618-5

Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study

2022

Journal Article

Improving paediatric antimicrobial stewardship in remote and regional Queensland hospitals: development and qualitative evaluation of a tailored intervention for intravenous-to-oral antibiotic switching

Sharman, Leah S., Avent, Minyon L., Lyall, Vivian, Fejzic, Jasmina, Clark, Julia E., Irwin, Adam, Graham, Nicolette and van Driel, Mieke L. (2022). Improving paediatric antimicrobial stewardship in remote and regional Queensland hospitals: development and qualitative evaluation of a tailored intervention for intravenous-to-oral antibiotic switching. BMJ Open, 12 (12) e064888, 1-10. doi: 10.1136/bmjopen-2022-064888

Improving paediatric antimicrobial stewardship in remote and regional Queensland hospitals: development and qualitative evaluation of a tailored intervention for intravenous-to-oral antibiotic switching

2022

Conference Publication

Optimising the management of vancomycin therapy utilisng co-design

Avent, M., Franks, W., Daveson, K., Redmond, A. and Naicker, S. (2022). Optimising the management of vancomycin therapy utilisng co-design. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA Australia, 27-30 November 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s2213-7165(22)00332-0

Optimising the management of vancomycin therapy utilisng co-design

2022

Conference Publication

Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model

Avent, Minyon, Mccarthy, Kate, Sime, Fekade, Naickera, Saiyuri, Heffernan, Aaron, Wallis, Steven, Paterson, David and Roberts, Jason A (2022). Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA, Australia, 27-30 November 2022. Amsterdam, Netherlands: Elsevier . doi: 10.1016/s2213-7165(22)00314-9

Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model

2022

Journal Article

Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model

Avent, Minyon L., McCarthy, Kate L., Sime, Fekade B., Naicker, Saiyuri, Heffernan, Aaron J., Wallis, Steven C., Paterson, David L. and Roberts, Jason A. (2022). Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model. Microbiology Spectrum, 10 (3), e0052522. doi: 10.1128/spectrum.00525-22

Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model

2022

Journal Article

An innovative Antimicrobial Stewardship Program for children in remote and regional areas in Queensland, Australia: optimizing antibiotic use through timely intravenous-to-oral conversion

Avent, M.L., Lee, X.J., Irwin, A.D., Graham, N., Brain, D., Fejzic, J., van Driel, M. and Clark, J.E. (2022). An innovative Antimicrobial Stewardship Program for children in remote and regional areas in Queensland, Australia: optimizing antibiotic use through timely intravenous-to-oral conversion. Journal of Global Antimicrobial Resistance, 28, 53-58. doi: 10.1016/j.jgar.2021.11.014

An innovative Antimicrobial Stewardship Program for children in remote and regional areas in Queensland, Australia: optimizing antibiotic use through timely intravenous-to-oral conversion

2021

Journal Article

Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia

Merlo, Gregory, Avent, Minyon, Yarwood, Trent, Smith, Bonnie, van Driel, Mieke and Hall, Lisa (2021). Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia. Antimicrobial Resistance and Infection Control, 10 (1) 85, 85. doi: 10.1186/s13756-021-00953-4

Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia

2021

Journal Article

Standard of practice in infectious diseases for pharmacy services

Cairns, Kelly A., Avent, Minyon, Buono, Evette, Cheah, Ron, Devchand, Misha, Khumra, Sharmila, Rawlins, Matthew, Roberts, Jason A., Xenos, Kristin and Munro, Courtney (2021). Standard of practice in infectious diseases for pharmacy services. Journal of Pharmacy Practice and Research, 51 (3), 247-264. doi: 10.1002/jppr.1744

Standard of practice in infectious diseases for pharmacy services

2021

Journal Article

Implementation of a novel antimicrobial stewardship strategy for rural facilities utilising telehealth

Avent, M.L., Walker, D., Yarwood, T., Malacova, E., Brown, C., Kariyawasam, N., Ashley, S. and Daveson, K. (2021). Implementation of a novel antimicrobial stewardship strategy for rural facilities utilising telehealth. International Journal of Antimicrobial Agents, 57 (6) 106346, 1-5. doi: 10.1016/j.ijantimicag.2021.106346

Implementation of a novel antimicrobial stewardship strategy for rural facilities utilising telehealth

2020

Journal Article

Antimicrobial stewardship in the primary care setting: from dream to reality?

Avent, M. L., Cosgrove, S. E., Price-Haywood, E. G. and van Driel, M. L. (2020). Antimicrobial stewardship in the primary care setting: from dream to reality?. BMC Family Practice, 21 (1) 134, 134. doi: 10.1186/s12875-020-01191-0

Antimicrobial stewardship in the primary care setting: from dream to reality?

2020

Journal Article

Oral or intravenous antibiotics?

McCarthy, Kate and Avent, Minyon (2020). Oral or intravenous antibiotics?. Australian Prescriber, 43 (2), 45-48. doi: 10.18773/austprescr.2020.008

Oral or intravenous antibiotics?

2020

Journal Article

Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection

McNamara, John F., Avent, Minyon, Stewart, Adam, Kwan, Christopher and Paterson, David L. (2020). Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection. Infection, Disease and Health, 25 (3), 151-157. doi: 10.1016/j.idh.2020.01.003

Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection

2019

Journal Article

Optimising antimicrobial therapy through the use of Bayesian dosing programs

Avent, M. L. and Rogers, B. A. (2019). Optimising antimicrobial therapy through the use of Bayesian dosing programs. International Journal of Clinical Pharmacy, 41 (5), 1121-1130. doi: 10.1007/s11096-019-00886-4

Optimising antimicrobial therapy through the use of Bayesian dosing programs

2018

Journal Article

Fosfomycin: what was old is new again

Avent, Minyon L., Rogers, Benjamin A., Cheng, Allen C., Athan, Eugene, Francis, Joshua R., Roberts, Matthew J., Paterson, David L. and Harris, Patrick N. A. (2018). Fosfomycin: what was old is new again. Internal Medicine Journal, 48 (12), 1425-1429. doi: 10.1111/imj.14122

Fosfomycin: what was old is new again

2018

Journal Article

An underutilised resource for Antimicrobial Stewardship: a ‘snapshot’ of the community pharmacists’ role in delayed or ‘wait and see’ antibiotic prescribing

Avent, Minyon L., Fejzic, Jasmina and van Driel, Mieke L. (2018). An underutilised resource for Antimicrobial Stewardship: a ‘snapshot’ of the community pharmacists’ role in delayed or ‘wait and see’ antibiotic prescribing. International Journal of Pharmacy Practice, 26 (4), 373-375. doi: 10.1111/ijpp.12431

An underutilised resource for Antimicrobial Stewardship: a ‘snapshot’ of the community pharmacists’ role in delayed or ‘wait and see’ antibiotic prescribing

2017

Journal Article

Combination antibiotic therapy for Pseudomonas aeruginosa bacteremia in febrile neutropenic patients? The question still remains

McCarthy, Kate L., Cherian, Jacob D., Avent, Minyon L. and Paterson, David L. (2017). Combination antibiotic therapy for Pseudomonas aeruginosa bacteremia in febrile neutropenic patients? The question still remains. Infectious Diseases, 50 (5), 403-406. doi: 10.1080/23744235.2017.1411605

Combination antibiotic therapy for Pseudomonas aeruginosa bacteremia in febrile neutropenic patients? The question still remains

2016

Journal Article

Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines

McMullan, Brendan J., Andresen, David, Blyth, Christopher C., Avent, Minyon L., Bowen, Asha C., Britton, Philip N., Clark, Julia E., Cooper, Celia M., Curtis, Nigel, Goeman, Emma, Hazelton, Briony, Haeusler, Gabrielle M., Khatami, Ameneh, Newcombe, James P., Osowicki, Joshua, Palasanthiran, Pamela, Starr, Mike, Lai, Tony, Nourse, Clare, Francis, Joshua R., Isaacs, David and Bryant, Penelope A. (2016). Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines. Lancet Infectious Diseases, 16 (8), E139-E152. doi: 10.1016/S1473-3099(16)30024-X

Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines

Funding

Past funding

  • 2018 - 2020
    An innovative Antimicrobial Stewardship Program for children in remote and regional areas: optimising antibiotic use through early intravenous-to-oral conversion
    The Children's Hospital Foundation
    Open grant
  • 2015 - 2016
    Development of evidence-based approaches that will improve antimicrobial stewardship and infection prevention and control in general practice settings
    Office of Health Protection, Department of Health
    Open grant
  • 2014 - 2018
    Randomised controlled study of an intense short course of optimised combination therapy versus conventional therapy for the management of Gram-negative bacteraemia
    Merck Sharp & Dohme Australia Grant for Pharmacotherapeutics in Infectious Diseases
    Open grant
  • 2012 - 2015
    Pilot Study of pharmacokinetic and pharmacodynamic assessment of monotherapy versus combination therapy for the management of gram negative bacteraemia
    Royal Brisbane and Women's Hospital
    Open grant

Supervision

Availability

Dr Minyon Avent is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Dr Minyon Avent's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au